Clicky

Charles River Laboratories International, Inc.(CRL) News

Date Title
Sep 9 CRL Stock May Benefit From New Neuroscience Research Collaboration
Sep 6 Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
Sep 6 Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
Sep 4 Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Sep 1 Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
Aug 28 Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
Jul 30 Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
Jul 24 Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
Jul 24 Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
Jul 9 Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
Jul 8 Charles River to Perform Plasmid Manufacturing for AAVantgarde
Jul 5 Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
Jun 25 Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Jun 18 ‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
Jun 18 Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Jun 18 Charles River and Captain T Cell sign vector production agreement
Jun 17 Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
May 30 Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
May 30 Reasons to Hold Charles River (CRL) in Your Portfolio Now
May 24 Charles River (CRL) Banks on RMS Growth Amid Competition